Delivery Order SPE2DB20D1109-SPE2DB22FP00V
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,620.56 firm fixed-price delivery order is for Dextroamphetamine-Amphetamine 30 mg capsules, with a performance period ending on September 20, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
- This federal contract award, valued at $3,492.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of dextroamphetamine-amphetamine 20 mg capsules. The $2,665.48 firm-fixed price delivery order has a completion date of May 27, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,599.40 firm fixed price delivery order is for the supply of 5 mg capsules of the amphetamine drug dextroamphetamine. The contract has an ultimate completion date of July 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,118.64 firm fixed-price delivery order is for the supply of 4,566,790,127 dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.54 firm fixed-price delivery order is for the supply of 4,568,234,911 units of the medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract has a period of performance through May 14, 2025 and is not set aside for any small business designation. AmerisourceBergen Drug Corp holds a significant...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Dextroamphetamine-amphetamine 10 mg capsules to the Defense Logistics Agency (DLA). The $3,168.00 Firm Fixed Price Delivery Order contract has a period of performance through February 2, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,185 units of dextroamphetamine-amphetamine 30 mg capsules. The $1,460.52 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,810.02 and is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award is a $1,286.83 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dextroamphetamine-amphetamine 10 mg capsules, a type of prescription medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP00VDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The $3,179.78 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC, which runs through November 2026, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits, to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/13/22 |